ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TELA vs SNWV // EV/EBITDA & P/E VALUATION

TELA Bio Inc. (NASDAQ) VS. SANUWAVE Health Inc. (NASDAQ) • 15-METRIC TALLY: TELA 0 — SNWV 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TELA VS. SNWV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TELA SNWV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 67.70% 77.10% -9.40 SNWV /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 67.30% -102.30 SNWV /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 7.5x — TIE /valuation <GO>
Free Cash Flow Yield — 4.27% — TIE /fcf-yield <GO>
Operating Margin -42.00% 11.20% -53.20 SNWV /operating-margins <GO>
Net Profit Margin -48.30% 26.80% -75.10 SNWV /net-margins <GO>
Revenue Growth (YoY) 15.80% 36.30% -20.50 SNWV /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 7/9 -3.00 SNWV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 33.8 50.4 -16.58 SNWV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 3.5x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $41.5M $45.3M -$3.8M SNWV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TELA REV SNWV REV TELA GROSS % SNWV GROSS % TELA FCF SNWV FCF
FY 2025 $80.3M $44.1M 67.7% 77.1% -$28.7M $1.9M
FY 2024 $69.3M $32.3M 67.1% 75.9% -$42.6M $2.0M
FY 2023 $58.5M $19.3M — — -$40.9M -$4.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TELA // BETA —
SNWV // BETA —